Advances in COVID-19 Prevention and Treatment Enabled by Structural Biology Research

The emergence of the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) -- the etiologic agent responsible for the current outbreak of COVID-19 -- mobilized research communities around the world to investigate the virus and the disease at unprecedented speed. To deliver information suitable for the development of vaccines, therapeutics, and diagnostics, researchers representing multiple disciplines and institutions quickly initiated broad collaborations, while DOE user facilities provided unlimited access to resources necessary for this research.